Carlos Alberto Chesta

Carlos Alberto Chesta

Auto-generated profile, based on publicly available information

Carlos Alberto Chesta

Instituto de Investigaciones en Tecnologías Energéticas y Materiales Avanzados (IITEMA), Universidad Nacional de Rio Cuarto (UNRC) y Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Río Cuarto X5800BIA, Argentina

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2020 in Nanomedicine
Verified
Journal Article
Closed access
Luis Exequiel IbarraLuis Exequiel Ibarra
Luis Exequiel Ibarra
LBLucía Beaugé
Lucía Beaugé
Nuria Arias RamosNuria Arias Ramos
Nuria Arias Ramos
VRViviana A Rivarola
Viviana A Rivarola
CCCarlos A Chesta
Carlos A Chesta
Rodrigo Emiliano PalaciosRodrigo Emiliano Palacios
Rodrigo Emiliano Palacios
Aim: To assess monocyte-based delivery of conjugated polymer nanoparticles (CPNs) for improved photodynamic therapy (PDT) in glioblastoma (GBM). Materials & methods: Human monocyte cells (THP-1) an... Graphical abstract

14 August 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Nuria Arias RamosNuria Arias Ramos
Nuria Arias Ramos
Luis Exequiel IbarraLuis Exequiel Ibarra
Luis Exequiel Ibarra
MSMaría Serrano-Torres
María Serrano-Torres
BYBalbino Yagüe
Balbino Yagüe
MCMatías Daniel Caverzan
Matías Daniel Caverzan
Pilar López-LarrubiaPilar López-Larrubia
Pilar López-Larrubia
Conjugated polymer nanoparticles (CPNs) have emerged as advanced polymeric nanoplatforms in biomedical applications by virtue of extraordinary properties including high fluorescence brightness, large absorption coefficients of one and two-photons, and excellent photostability and colloidal stability in water and physiological medium. In addition, low cytotoxicity, easy functionalization, and the ability to modify CPN photochemical properties by the incorporation of dopants, convert them into excellent theranostic agents with multifunctionality for imaging and treatment. In this work, CPNs were designed and synthesized by incorporating a metal oxide magnetic core (Fe3O4 and NiFe2O4 nanoparticles, 5 nm) into their matrix during the nanoprecipitation method. This modification allowed the in vivo monitoring of nanoparticles in animal models using magnetic resonance imaging (MRI) and intravital fluorescence, techniques widely used for intracranial tumors evaluation. The modified CPNs were assessed in vivo in glioblastoma (GBM) bearing mice, both heterotopic and orthotopic developed models. Biodistribution studies were performed with MRI acquisitions and fluorescence images up to 24 h after the i.v. nanoparticles administration. The resulting IONP-doped CPNs were biocompatible in GBM tumor cells in vitro with an excellent cell incorporation depending on nanoparticle concentration exposure. IONP-doped CPNs were detected in tumor and excretory organs of the heterotopic GBM model after i.v. and i.t. injection. However, in the orthotopic GBM model, the size of the nanoparticles is probably hindering a higher effect on intratumorally T2-weighted images (T2WI) signals and T2 values. The photodynamic therapy (PDT)—cytotoxicity of CPNs was not either affected by the IONPs incorporation into the nanoparticles.

12 March 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Luis Exequiel IbarraLuis Exequiel Ibarra
Luis Exequiel Ibarra
Simona CamoraniSimona Camorani
Simona Camorani
LALisa Agnello
Lisa Agnello
Emilia PedoneEmilia Pedone
Emilia Pedone
Luciano PironeLuciano Pirone
Luciano Pirone
Laura CerchiaLaura Cerchia
Laura Cerchia
Photodynamic therapy (PDT) may be an excellent alternative in the treatment of breast cancer, mainly for the most aggressive type with limited targeted therapies such as triple-negative breast cancer (TNBC). We recently generated conjugated polymer nanoparticles (CPNs) as efficient photosensitizers for the photo-eradication of different cancer cells. With the aim of improving the selectivity of PDT with CPNs, the nanoparticle surface conjugation with unique 2’-Fluoropyrimidines-RNA-aptamers that act as effective recognition elements for functional surface signatures of TNBC cells was proposed and designed. A coupling reaction with carbodiimide was used to covalently bind NH2-modified aptamers with CPNs synthetized with two polystyrene-based polymer donors of COOH groups for the amide reaction. The selectivity of recognition for TNBC membrane receptors and PDT efficacy were assayed in TNBC cells and compared with non-TNBC cells by flow cytometry and cell viability assays. Furthermore, in vitro PDT efficacy was assayed in different TNBC cells with significant improvement results using CL4, sTN29 and sTN58 aptamers compared to unconjugated CPNs and SCR non-specific aptamer. In a chemoresistance TNBC cell model, sTN58 was the candidate for improving labelling and PDT efficacy with CPNs. We proposed sTN58, sTN29 and CL4 aptamers as valuable tools for selective TNBC targeting, cell internalization and therapeutic improvements for CPNs in PDT protocols.

4 June 2023 in Cells
Verified
Journal Article
Open access
PDF file
MCMatías Daniel Caverzan
Matías Daniel Caverzan
POPaula Martina Oliveda
Paula Martina Oliveda
LBLucía Beaugé
Lucía Beaugé
Rodrigo Emiliano PalaciosRodrigo Emiliano Palacios
Rodrigo Emiliano Palacios
CCCarlos Alberto Chesta
Carlos Alberto Chesta
Luis Exequiel IbarraLuis Exequiel Ibarra
Luis Exequiel Ibarra
Alternative therapies such as photodynamic therapy (PDT) that combine light, oxygen and photosensitizers (PSs) have been proposed for glioblastoma (GBM) management to overcome conventional treatment issues. An important disadvantage of PDT using a high light irradiance (fluence rate) (cPDT) is the abrupt oxygen consumption that leads to resistance to the treatment. PDT metronomic regimens (mPDT) involving administering light at a low irradiation intensity over a relatively long period of time could be an alternative to circumvent the limitations of conventional PDT protocols. The main objective of the present work was to compare the effectiveness of PDT with an advanced PS based on conjugated polymer nanoparticles (CPN) developed by our group in two irradiation modalities: cPDT and mPDT. The in vitro evaluation was carried out based on cell viability, the impact on the macrophage population of the tumor microenvironment in co-culture conditions and the modulation of HIF-1α as an indirect indicator of oxygen consumption. mPDT regimens with CPNs resulted in more effective cell death, a lower activation of molecular pathways of therapeutic resistance and macrophage polarization towards an antitumoral phenotype. Additionally, mPDT was tested in a GBM heterotopic mouse model, confirming its good performance with promising tumor growth inhibition and apoptotic cell death induction.

6 July 2022 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
RPRodrigo A. Ponzio
Rodrigo A. Ponzio
Luis Exequiel IbarraLuis Exequiel Ibarra
Luis Exequiel Ibarra
EAEstefanía E. Achilli
Estefanía E. Achilli
EOEmmanuel Odella
Emmanuel Odella
CCCarlos A. Chesta
Carlos A. Chesta
Rodrigo Emiliano PalaciosRodrigo Emiliano Palacios
Rodrigo Emiliano Palacios

1 January 2015 in Dyes and Pigments
Verified
Journal Article
Closed access
GJGabriel Ernesto Jara
Gabriel Ernesto Jara
CSClaudia A. Solis
Claudia A. Solis
NGNatalia S. Gsponer
Natalia S. Gsponer
JTJuan J. Torres
Juan J. Torres
CGCarlos A. Glusko
Carlos A. Glusko
HMHernán A. Montejano
Hernán A. Montejano